| bibliographicCitation |
Appay R, Tabouret E, Macagno N, Touat M, Carpentier C, Colin C, Ducray F, Idbaih A, Mokhtari K, Uro-Coste E, Dehais C, Figarella-Branger D, Desenclos C, Sevestre H, Menei P, Rousseau A, Cruel T, Lopez S, Mihai M, Petit A, Adam C, Parker F, Dam-Hieu P, Quintin-Roué I, Eimer S, Loiseau H, Bekaert L, Chapon F, Ricard D, Godfraind C, Khallil T, Cazals-Hatem D, Faillot T, Gaultier C, Tortel MC, Carpiuc I, Richard P, Lahiani W, Aubriot-Lorton H, Ghiringhelli F, Maurage CA, Ramirez C, Gueye EM, Labrousse F, Chinot O, Bauchet L, Rigau V, Beauchesne P, Gauchotte G, Campone M, Loussouarn D, Fontaine D, Vandenbos-Burel F, Le Floch A, Roger P, Blechet C, Fesneau M, Carpentier A, Delattre JY, Elouadhani-Hamdi S, Polivka M, Larrieu-Ciron D, Milin S, Colin P, Diebold MD, Chiforeanu D, Vauleon E, Langlois O, Laquerriere A, Forest F, Motso-Fotso MJ, Andraud M, Runavot G, Lhermitte B, Noel G, Gaillard S, Villa C, Desse N, Rousselot-Denis C, Zemmoura I, Cohen-Moyal E, Uro-Coste E, Dhermain F, . IDH2 mutations are commonly associated with 1p/19q codeletion in diffuse adult gliomas. 2018 Mar 07;(). doi: 10.1093/neuonc/noy014. |